Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vaxcyte, Inc.

35.39
+0.15000.43%
Post-market: 35.440.0500+0.14%18:53 EDT
Volume:1.94M
Turnover:69.58M
Market Cap:4.57B
PE:-9.31
High:36.71
Open:35.75
Low:34.90
Close:35.24
Loading ...
May 01, 2025

Major Issues Report

Form 8-K - Current report
Mar 31, 2025

Major Issues Report

Form 8-K - Current report
Mar 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 25, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 25, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2025

Major Issues Report

Form 8-K - Current report
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 21, 2024

Major Issues Report

Form 8-K - Current report